Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Stecenko

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
New Horizons (Baltimore, Md.)|May 1, 1995
Gene therapy in acute critical illnessK L Brigham, A A Stecenko
Gene Therapy|February 7, 2003
Gene therapy progress and prospects: alpha-1 antitrypsinA A Stecenko, K L Brigham
The American Review of Respiratory Disease|November 1, 1991
Phascinating physiologyA A Stecenko, A A Hutchison
Intensive Care Medicine|April 29, 2000
Gene therapy for acute lung injuryK L Brigham, A A Stecenko
Pediatric Pulmonology|January 1, 1989
Predicting arterial oxygen tension from maximum expiratory flow volume curves in cystic fibrosisA A Stecenko, L Postotnik, R G Thomas
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1986
Effect of age on lung mechanics and airway reactivity in lambsR A Sauder, K J McNicol, A A Stecenko
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 19, 2001
Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorderT S Blackwell, A A Stecenko, J W Christman
American Journal of Respiratory and Critical Care Medicine|June 14, 2000
Respiratory-related evoked potentials in children with life-threatening asthmaP W Davenport, M Cruz, A A Stecenko, et al.
Pediatric Pulmonology|April 1, 1994
Evaluation of the interrupter technique for the use of assessing airway obstruction in childrenE R Carter, A A Stecenko, B H Pollock, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 8, 2014
Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose toleranceL Merjaneh, Q He, Q Long, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
New Horizons (Baltimore, Md.)|May 1, 1995
Gene therapy in acute critical illnessK L Brigham, A A Stecenko
Gene Therapy|February 7, 2003
Gene therapy progress and prospects: alpha-1 antitrypsinA A Stecenko, K L Brigham
The American Review of Respiratory Disease|November 1, 1991
Phascinating physiologyA A Stecenko, A A Hutchison
Intensive Care Medicine|April 29, 2000
Gene therapy for acute lung injuryK L Brigham, A A Stecenko
Pediatric Pulmonology|January 1, 1989
Predicting arterial oxygen tension from maximum expiratory flow volume curves in cystic fibrosisA A Stecenko, L Postotnik, R G Thomas
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1986
Effect of age on lung mechanics and airway reactivity in lambsR A Sauder, K J McNicol, A A Stecenko
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 19, 2001
Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorderT S Blackwell, A A Stecenko, J W Christman
American Journal of Respiratory and Critical Care Medicine|June 14, 2000
Respiratory-related evoked potentials in children with life-threatening asthmaP W Davenport, M Cruz, A A Stecenko, et al.
Pediatric Pulmonology|April 1, 1994
Evaluation of the interrupter technique for the use of assessing airway obstruction in childrenE R Carter, A A Stecenko, B H Pollock, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 8, 2014
Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose toleranceL Merjaneh, Q He, Q Long, et al.
Pageof 2